Global Adult Hemoglobinopathy Testing Industry

Global Adult Hemoglobinopathy Testing Market to Reach $392. 4 Million by 2027. Amid the COVID-19 crisis, the global market for Adult Hemoglobinopathy Testing estimated at US$330. 3 Million in the year 2020, is projected to reach a revised size of US$392.

New York, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Adult Hemoglobinopathy Testing Industry" - https://www.reportlinker.com/p05955753/?utm_source=GNW
4 Million by 2027, growing at a CAGR of 2.5% over the analysis period 2020-2027. HPLC Test, one of the segments analyzed in the report, is projected to record a 2% CAGR and reach US$239.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mass Spectrometry segment is readjusted to a revised 2.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $89.4 Million, While China is Forecast to Grow at 4.7% CAGR

The Adult Hemoglobinopathy Testing market in the U.S. is estimated at US$89.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$77.7 Million by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.6% and 1.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.1% CAGR.

Hb Electrophoresis Segment to Record 4.7% CAGR

In the global Hb Electrophoresis segment, USA, Canada, Japan, China and Europe will drive the 4.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$38 Million in the year 2020 will reach a projected size of US$50.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$53.7 Million by the year 2027, while Latin America will expand at a 5.7% CAGR through the analysis period. We bring years of research experience to this 7th edition of our report. The 281-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

• BioMedomics Inc.

• Bio-Rad Laboratories, Inc.

• Chromsystems Instruments & Chemicals GmbH

• PerkinElmer, Inc.

• Streck, Inc.

• Thermo Fisher Scientific, Inc.

• Trinity Biotech PLC

Read the full report: https://www.reportlinker.com/p05955753/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Adult Hemoglobinopathy Testing Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Adult
Hemoglobinopathy Testing by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027

Table 2: World Historic Review for Adult Hemoglobinopathy
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019

Table 3: World 15-Year Perspective for Adult Hemoglobinopathy
Testing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2020 & 2027

Table 4: World Current & Future Analysis for HPLC Test by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 5: World Historic Review for HPLC Test by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 6: World 15-Year Perspective for HPLC Test by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Mass Spectrometry
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 8: World Historic Review for Mass Spectrometry by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 9: World 15-Year Perspective for Mass Spectrometry by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Hb
Electrophoresis by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027

Table 11: World Historic Review for Hb Electrophoresis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 12: World 15-Year Perspective for Hb Electrophoresis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 14: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 15: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Reference
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027

Table 17: World Historic Review for Reference Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 18: World 15-Year Perspective for Reference Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Academic &
Medical Institutes by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027

Table 20: World Historic Review for Academic & Medical
Institutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019

Table 21: World 15-Year Perspective for Academic & Medical
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Adult Hemoglobinopathy Testing Market Share (in %) by
Company: 2019 & 2025
Market Analytics
Table 22: USA Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 23: USA Historic Review for Adult Hemoglobinopathy
Testing by Test Type - HPLC Test, Mass Spectrometry and Hb
Electrophoresis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 24: USA 15-Year Perspective for Adult Hemoglobinopathy
Testing by Test Type - Percentage Breakdown of Value Sales for
HPLC Test, Mass Spectrometry and Hb Electrophoresis for the
Years 2012, 2020 & 2027

Table 25: USA Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 26: USA Historic Review for Adult Hemoglobinopathy
Testing by End-Use - Hospitals, Reference Laboratories and
Academic & Medical Institutes Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 27: USA 15-Year Perspective for Adult Hemoglobinopathy
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Reference Laboratories and Academic & Medical
Institutes for the Years 2012, 2020 & 2027

CANADA
Table 28: Canada Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 29: Canada Historic Review for Adult Hemoglobinopathy
Testing by Test Type - HPLC Test, Mass Spectrometry and Hb
Electrophoresis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 30: Canada 15-Year Perspective for Adult Hemoglobinopathy
Testing by Test Type - Percentage Breakdown of Value Sales for
HPLC Test, Mass Spectrometry and Hb Electrophoresis for the
Years 2012, 2020 & 2027

Table 31: Canada Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 32: Canada Historic Review for Adult Hemoglobinopathy
Testing by End-Use - Hospitals, Reference Laboratories and
Academic & Medical Institutes Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 33: Canada 15-Year Perspective for Adult Hemoglobinopathy
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Reference Laboratories and Academic & Medical
Institutes for the Years 2012, 2020 & 2027

JAPAN
Table 34: Japan Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 35: Japan Historic Review for Adult Hemoglobinopathy
Testing by Test Type - HPLC Test, Mass Spectrometry and Hb
Electrophoresis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 36: Japan 15-Year Perspective for Adult Hemoglobinopathy
Testing by Test Type - Percentage Breakdown of Value Sales for
HPLC Test, Mass Spectrometry and Hb Electrophoresis for the
Years 2012, 2020 & 2027

Table 37: Japan Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 38: Japan Historic Review for Adult Hemoglobinopathy
Testing by End-Use - Hospitals, Reference Laboratories and
Academic & Medical Institutes Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 39: Japan 15-Year Perspective for Adult Hemoglobinopathy
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Reference Laboratories and Academic & Medical
Institutes for the Years 2012, 2020 & 2027

CHINA
Table 40: China Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 41: China Historic Review for Adult Hemoglobinopathy
Testing by Test Type - HPLC Test, Mass Spectrometry and Hb
Electrophoresis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 42: China 15-Year Perspective for Adult Hemoglobinopathy
Testing by Test Type - Percentage Breakdown of Value Sales for
HPLC Test, Mass Spectrometry and Hb Electrophoresis for the
Years 2012, 2020 & 2027

Table 43: China Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 44: China Historic Review for Adult Hemoglobinopathy
Testing by End-Use - Hospitals, Reference Laboratories and
Academic & Medical Institutes Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 45: China 15-Year Perspective for Adult Hemoglobinopathy
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Reference Laboratories and Academic & Medical
Institutes for the Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
European Adult Hemoglobinopathy Testing Market: Competitor
Market Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 46: Europe Current & Future Analysis for Adult
Hemoglobinopathy Testing by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 47: Europe Historic Review for Adult Hemoglobinopathy
Testing by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 48: Europe 15-Year Perspective for Adult Hemoglobinopathy
Testing by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2020 & 2027

Table 49: Europe Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 50: Europe Historic Review for Adult Hemoglobinopathy
Testing by Test Type - HPLC Test, Mass Spectrometry and Hb
Electrophoresis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 51: Europe 15-Year Perspective for Adult Hemoglobinopathy
Testing by Test Type - Percentage Breakdown of Value Sales for
HPLC Test, Mass Spectrometry and Hb Electrophoresis for the
Years 2012, 2020 & 2027

Table 52: Europe Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 53: Europe Historic Review for Adult Hemoglobinopathy
Testing by End-Use - Hospitals, Reference Laboratories and
Academic & Medical Institutes Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 54: Europe 15-Year Perspective for Adult Hemoglobinopathy
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Reference Laboratories and Academic & Medical
Institutes for the Years 2012, 2020 & 2027

FRANCE
Table 55: France Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 56: France Historic Review for Adult Hemoglobinopathy
Testing by Test Type - HPLC Test, Mass Spectrometry and Hb
Electrophoresis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 57: France 15-Year Perspective for Adult Hemoglobinopathy
Testing by Test Type - Percentage Breakdown of Value Sales for
HPLC Test, Mass Spectrometry and Hb Electrophoresis for the
Years 2012, 2020 & 2027

Table 58: France Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 59: France Historic Review for Adult Hemoglobinopathy
Testing by End-Use - Hospitals, Reference Laboratories and
Academic & Medical Institutes Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 60: France 15-Year Perspective for Adult Hemoglobinopathy
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Reference Laboratories and Academic & Medical
Institutes for the Years 2012, 2020 & 2027

GERMANY
Table 61: Germany Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 62: Germany Historic Review for Adult Hemoglobinopathy
Testing by Test Type - HPLC Test, Mass Spectrometry and Hb
Electrophoresis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 63: Germany 15-Year Perspective for Adult
Hemoglobinopathy Testing by Test Type - Percentage Breakdown of
Value Sales for HPLC Test, Mass Spectrometry and Hb
Electrophoresis for the Years 2012, 2020 & 2027

Table 64: Germany Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 65: Germany Historic Review for Adult Hemoglobinopathy
Testing by End-Use - Hospitals, Reference Laboratories and
Academic & Medical Institutes Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 66: Germany 15-Year Perspective for Adult
Hemoglobinopathy Testing by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Reference Laboratories and Academic &
Medical Institutes for the Years 2012, 2020 & 2027

ITALY
Table 67: Italy Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 68: Italy Historic Review for Adult Hemoglobinopathy
Testing by Test Type - HPLC Test, Mass Spectrometry and Hb
Electrophoresis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 69: Italy 15-Year Perspective for Adult Hemoglobinopathy
Testing by Test Type - Percentage Breakdown of Value Sales for
HPLC Test, Mass Spectrometry and Hb Electrophoresis for the
Years 2012, 2020 & 2027

Table 70: Italy Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 71: Italy Historic Review for Adult Hemoglobinopathy
Testing by End-Use - Hospitals, Reference Laboratories and
Academic & Medical Institutes Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 72: Italy 15-Year Perspective for Adult Hemoglobinopathy
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Reference Laboratories and Academic & Medical
Institutes for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 73: UK Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 74: UK Historic Review for Adult Hemoglobinopathy Testing
by Test Type - HPLC Test, Mass Spectrometry and Hb
Electrophoresis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 75: UK 15-Year Perspective for Adult Hemoglobinopathy
Testing by Test Type - Percentage Breakdown of Value Sales for
HPLC Test, Mass Spectrometry and Hb Electrophoresis for the
Years 2012, 2020 & 2027

Table 76: UK Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 77: UK Historic Review for Adult Hemoglobinopathy Testing
by End-Use - Hospitals, Reference Laboratories and Academic &
Medical Institutes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 78: UK 15-Year Perspective for Adult Hemoglobinopathy
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Reference Laboratories and Academic & Medical
Institutes for the Years 2012, 2020 & 2027

SPAIN
Table 79: Spain Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 80: Spain Historic Review for Adult Hemoglobinopathy
Testing by Test Type - HPLC Test, Mass Spectrometry and Hb
Electrophoresis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 81: Spain 15-Year Perspective for Adult Hemoglobinopathy
Testing by Test Type - Percentage Breakdown of Value Sales for
HPLC Test, Mass Spectrometry and Hb Electrophoresis for the
Years 2012, 2020 & 2027

Table 82: Spain Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 83: Spain Historic Review for Adult Hemoglobinopathy
Testing by End-Use - Hospitals, Reference Laboratories and
Academic & Medical Institutes Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 84: Spain 15-Year Perspective for Adult Hemoglobinopathy
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Reference Laboratories and Academic & Medical
Institutes for the Years 2012, 2020 & 2027

RUSSIA
Table 85: Russia Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 86: Russia Historic Review for Adult Hemoglobinopathy
Testing by Test Type - HPLC Test, Mass Spectrometry and Hb
Electrophoresis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 87: Russia 15-Year Perspective for Adult Hemoglobinopathy
Testing by Test Type - Percentage Breakdown of Value Sales for
HPLC Test, Mass Spectrometry and Hb Electrophoresis for the
Years 2012, 2020 & 2027

Table 88: Russia Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 89: Russia Historic Review for Adult Hemoglobinopathy
Testing by End-Use - Hospitals, Reference Laboratories and
Academic & Medical Institutes Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 90: Russia 15-Year Perspective for Adult Hemoglobinopathy
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Reference Laboratories and Academic & Medical
Institutes for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 91: Rest of Europe Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 92: Rest of Europe Historic Review for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 93: Rest of Europe 15-Year Perspective for Adult
Hemoglobinopathy Testing by Test Type - Percentage Breakdown of
Value Sales for HPLC Test, Mass Spectrometry and Hb
Electrophoresis for the Years 2012, 2020 & 2027

Table 94: Rest of Europe Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 95: Rest of Europe Historic Review for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 96: Rest of Europe 15-Year Perspective for Adult
Hemoglobinopathy Testing by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Reference Laboratories and Academic &
Medical Institutes for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 97: Asia-Pacific Current & Future Analysis for Adult
Hemoglobinopathy Testing by Geographic Region - Australia,
India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 98: Asia-Pacific Historic Review for Adult
Hemoglobinopathy Testing by Geographic Region - Australia,
India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 99: Asia-Pacific 15-Year Perspective for Adult
Hemoglobinopathy Testing by Geographic Region - Percentage
Breakdown of Value Sales for Australia, India, South Korea and
Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 100: Asia-Pacific Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 101: Asia-Pacific Historic Review for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 102: Asia-Pacific 15-Year Perspective for Adult
Hemoglobinopathy Testing by Test Type - Percentage Breakdown of
Value Sales for HPLC Test, Mass Spectrometry and Hb
Electrophoresis for the Years 2012, 2020 & 2027

Table 103: Asia-Pacific Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 104: Asia-Pacific Historic Review for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 105: Asia-Pacific 15-Year Perspective for Adult
Hemoglobinopathy Testing by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Reference Laboratories and Academic &
Medical Institutes for the Years 2012, 2020 & 2027

AUSTRALIA
Table 106: Australia Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 107: Australia Historic Review for Adult Hemoglobinopathy
Testing by Test Type - HPLC Test, Mass Spectrometry and Hb
Electrophoresis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 108: Australia 15-Year Perspective for Adult
Hemoglobinopathy Testing by Test Type - Percentage Breakdown of
Value Sales for HPLC Test, Mass Spectrometry and Hb
Electrophoresis for the Years 2012, 2020 & 2027

Table 109: Australia Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 110: Australia Historic Review for Adult Hemoglobinopathy
Testing by End-Use - Hospitals, Reference Laboratories and
Academic & Medical Institutes Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 111: Australia 15-Year Perspective for Adult
Hemoglobinopathy Testing by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Reference Laboratories and Academic &
Medical Institutes for the Years 2012, 2020 & 2027

INDIA
Table 112: India Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 113: India Historic Review for Adult Hemoglobinopathy
Testing by Test Type - HPLC Test, Mass Spectrometry and Hb
Electrophoresis Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 114: India 15-Year Perspective for Adult Hemoglobinopathy
Testing by Test Type - Percentage Breakdown of Value Sales for
HPLC Test, Mass Spectrometry and Hb Electrophoresis for the
Years 2012, 2020 & 2027

Table 115: India Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 116: India Historic Review for Adult Hemoglobinopathy
Testing by End-Use - Hospitals, Reference Laboratories and
Academic & Medical Institutes Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 117: India 15-Year Perspective for Adult Hemoglobinopathy
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Reference Laboratories and Academic & Medical
Institutes for the Years 2012, 2020 & 2027

SOUTH KOREA
Table 118: South Korea Current & Future Analysis for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 119: South Korea Historic Review for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 120: South Korea 15-Year Perspective for Adult
Hemoglobinopathy Testing by Test Type - Percentage Breakdown of
Value Sales for HPLC Test, Mass Spectrometry and Hb
Electrophoresis for the Years 2012, 2020 & 2027

Table 121: South Korea Current & Future Analysis for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 122: South Korea Historic Review for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 123: South Korea 15-Year Perspective for Adult
Hemoglobinopathy Testing by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Reference Laboratories and Academic &
Medical Institutes for the Years 2012, 2020 & 2027

REST OF ASIA-PACIFIC
Table 124: Rest of Asia-Pacific Current & Future Analysis for
Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 125: Rest of Asia-Pacific Historic Review for Adult
Hemoglobinopathy Testing by Test Type - HPLC Test, Mass
Spectrometry and Hb Electrophoresis Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 126: Rest of Asia-Pacific 15-Year Perspective for Adult
Hemoglobinopathy Testing by Test Type - Percentage Breakdown of
Value Sales for HPLC Test, Mass Spectrometry and Hb
Electrophoresis for the Years 2012, 2020 & 2027

Table 127: Rest of Asia-Pacific Current & Future Analysis for
Adult Hemoglobinopathy Testing by End-Use - Hospitals,
Reference Laboratories and Academic & Medical Institutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 128: Rest of Asia-Pacific Historic Review for Adult
Hemoglobinopathy Testing by End-Use - Hospitals, Reference
Laboratories and Academic & Medical Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 129: Rest of Asia-Pacific 15-Year Perspective for Adult
Hemoglobinopathy Testing by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Reference Laboratories and Academic &
Medical Institutes for the Years 2012, 2020 & 2027

LATIN AMERICA
Table 130: Latin America Current & Future Analysis for Adult
Hemoglobinopathy Testing by Geographic Region - Argentina,
Brazil, Mexico and Rest of Latin America Markets - Independent

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05955753/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001